Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7283241, 10 pages
https://doi.org/10.1155/2017/7283241
Research Article

Wu-Mei-Wan Reduces Insulin Resistance via Inhibition of NLRP3 Inflammasome Activation in HepG2 Cells

1Institute of Integrative Traditional Chinese & Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
2Department of Traditional Chinese Medicine, Puai Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430033, China
3Department of Integrative Traditional Chinese & Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China

Correspondence should be addressed to Guang Chen; moc.621@nahuwgg and Fuer Lu; nc.ude.umjt.hjt@ulef

Received 25 April 2017; Accepted 2 July 2017; Published 27 August 2017

Academic Editor: Darren R. Williams

Copyright © 2017 Xueping Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Saltiel, “New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes,” Cell, vol. 104, no. 4, pp. 517–529, 2001. View at Publisher · View at Google Scholar
  2. N. S. Kalupahana, N. Moustaid-Moussa, and K. J. Claycombe, “Immunity as a link between obesity and insulin resistance,” Molecular Aspects of Medicine, vol. 33, no. 1, pp. 26–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Cordain, M. R. Eades, and M. D. Eades, “Hyperinsulinemic diseases of civilization: More than just Syndrome X,” Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology, vol. 136, no. 1, pp. 95–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Xie, W. Wang, H. Su, D. Xing, Y. Pan, and L. Du, “Effect of ethanolic extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2,” Comparative Biochemistry and Physiology C: Toxicology & Pharmacology, vol. 143, no. 4, pp. 429–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006. View at Google Scholar · View at Scopus
  6. O. Nov, A. Kohl, E. C. Lewis et al., “Interleukin-1β may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation,” Endocrinology, vol. 151, no. 9, pp. 4247–4256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Jager, T. Grémeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti, “Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression,” Endocrinology, vol. 148, no. 1, pp. 241–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Schroder, R. Zhou, and J. Tschopp, “The NLRP3 inflammasome: a sensor for metabolic danger?” Science, vol. 327, no. 5963, pp. 296–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Wen, D. Gris, Y. Lei et al., “Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling,” Nature Immunology, vol. 12, no. 5, pp. 408–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-B. Li, L.-J. Xu, H. Dong et al., “Effects of Chinese Fructus Mume formula and its separated prescription extract on insulin resistance in type 2 diabetic rats,” Journal of Huazhong University of Science and Technology - Medical Science, vol. 33, no. 6, pp. 877–885, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gurnell, D. B. Savage, V. K. Chatterjee, and S. O’Rahilly, “The metabolic syndrome: peroxisome proliferator-activated receptor γ and its therapeutic modulation,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 6, pp. 2412–2421, 2003. View at Publisher · View at Google Scholar
  12. Y. Yuan, X. Wang, X. Lu, Y. Marunaka, and X. Wang, “Effect of Coptidis rhizoma extracts in a water-based solution on insulin resistance in 3T3-L1 adipocytes,” Biomedical Research (Japan), vol. 35, no. 5, pp. 321–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-M. Cheon, D.-I. Kim, and K.-S. Kim, “Insulin sensitivity improvement of fermented Korean red ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice,” Journal of Ginseng Research, vol. 39, no. 4, pp. 331–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. I.-M. Liu, T.-F. Tzeng, S.-S. Liou, and C. J. Chang, “Angelica acutiloba root attenuates insulin resistance induced by high-fructose diet in rats,” Phytotherapy Research, vol. 25, no. 9, pp. 1283–1293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Lu, Y. Li, and L. Z. Wang, “Explorations on the mechanisms behind the blood glucose-lowering effct of Wumei Pill,” Chinese Archives of Traditional Chinese Medicine, vol. 23, no. 5, pp. 292-293, 2005. View at Google Scholar
  16. X. Tu, C. G. Xie, F. Wang et al., “Fructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 787459, 8 pages, 2013. View at Publisher · View at Google Scholar
  17. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. V. T. Samuel, K. F. Petersen, and G. I. Shulman, “Lipid-induced insulin resistance: unravelling the mechanism,” The Lancet, vol. 375, no. 9733, pp. 2267–2277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Gao, S. Nong, X. Huang et al., “The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38 MAPK pathways,” The Journal of Biological Chemistry, vol. 285, no. 39, pp. 29965–29973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. L. Whiteman, H. Cho, and M. J. Birnbaum, “Role of Akt/protein kinase B in metabolism,” Trends in Endocrinology and Metabolism, vol. 13, no. 10, pp. 444–451, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M. F. White, “The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307,” Journal of Biological Chemistry, vol. 275, no. 12, pp. 9047–9054, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Aguirre, E. D. Werner, J. Giraud, Y. H. Lee, S. E. Shoelson, and M. F. White, “Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action,” Journal of Biological Chemistry, vol. 277, no. 2, pp. 1531–1537, 2002. View at Publisher · View at Google Scholar
  23. M. Fujishiro, Y. Gotoh, H. Katagiri et al., “MKK6/3 and p38 MAPK Pathway Activation Is Not Necessary for Insulin-induced Glucose Uptake but Regulates Glucose Transporter Expression,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 19800–19806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. H. Akash, Q. Shen, K. Rehman, and S. Chen, “Interleukin-1 receptor antagonist: A new therapy for type 2 diabetes mellitus,” Journal of Pharmaceutical Sciences, vol. 101, no. 5, pp. 1647–1658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Stienstra, L. A. B. Joosten, T. Koenen et al., “The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity,” Cell Metabolism, vol. 12, no. 6, pp. 593–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Swaroop, D. Rajarajeswari, and J. N. Naidu, “Association of TNF-α with insulin resistance in type 2 diabetes mellitus,” Indian Journal of Medical Research, vol. 135, no. 1, pp. 127–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Bryant and K. A. Fitzgerald, “Molecular mechanisms involved in inflammasome activation,” Trends in Cell Biology, vol. 19, no. 9, pp. 455–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Qiu, G. Hou, and D. N. Huang, “Molecular mechanism of TNF-a signal transduction,” Chinese Journal of Biochemistry and Molecular Biology, vol. 23, no. 6, pp. 430–435, 2007. View at Google Scholar
  30. M. T. Chow, H. Duret, D. M. Andrews et al., “Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome priming,” European Journal of Immunology, vol. 44, no. 7, pp. 2111–2120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Nakamura, T. Takamura, N. Matsuzawa-Nagata et al., “Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria,” Journal of Biological Chemistry, vol. 284, no. 22, pp. 14809–14818, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-Y. Ou, H.-T. Wu, H.-C. Hung, Y.-C. Yang, J.-S. Wu, and C.-J. Chang, “Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance,” Endocrinology, vol. 153, no. 7, pp. 2974–2984, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Dostert, V. Pétrilli, R. van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, “Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica,” Science, vol. 320, no. 5876, pp. 674–677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Li, J. Yang, M.-H. Chen et al., “Ilexgenin A inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP/NLRP3 inflammasome activation in an AMPK dependent manner,” Pharmacological Research, vol. 99, pp. 101–115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Vandanmagsar, Y.-H. Youm, A. Ravussin et al., “The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance,” Nature Medicine, vol. 17, no. 2, pp. 179–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Stienstra, J. A. van Diepen, C. J. Tack et al., “Inflammasome is a central player in the induction of obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15324–15329, 2011. View at Publisher · View at Google Scholar · View at Scopus